LEXARIA BIOSCIENCE CORP. Net Income (Loss) Attributable to Noncontrolling Interest
LEXARIA BIOSCIENCE CORP. (LEXX) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$1.78 thousand for the 3-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-05-31 was -$1.78K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-02-28 was -$2.75K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-11-30 was -$2.50K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-08-31 was -$1.39K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$9.59K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$13.31K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$47.63K.
- LEXARIA BIOSCIENCE CORP. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$114.33K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 1 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | -$1.78K 10-Q · filed 2026-07-13 | -$4.53K derived: sum of 2 quarters · filed 2026-07-13 | -$7.03K 10-Q · filed 2026-07-13 | -$8.42K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2026-02-28 | -$2.75K 10-Q · filed 2026-07-13 | -$5.25K 10-Q · filed 2026-04-13 | -$6.64K derived: sum of 3 quarters · filed 2026-07-13 | -$8.15K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-11-30 | -$2.50K 10-Q · filed 2026-07-13 | -$3.89K derived: sum of 2 quarters · filed 2026-07-13 | -$5.40K derived: sum of 3 quarters · filed 2026-07-13 | -$9.16K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-08-31 | -$1.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | -$2.90K derived: sum of 2 quarters · filed 2026-07-13 | -$6.66K derived: sum of 3 quarters · filed 2026-07-13 | -$9.59K 10-K · filed 2025-11-28 | |
| 2025-05-31 | -$1.51K 10-Q · filed 2026-07-13 | -$5.27K derived: sum of 2 quarters · filed 2026-07-13 | -$8.20K 10-Q · filed 2026-07-13 | -$9.98K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2025-02-28 | -$3.76K 10-Q · filed 2026-07-13 | -$6.69K 10-Q · filed 2026-04-13 | -$8.47K derived: sum of 3 quarters · filed 2026-07-13 | -$11.09K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2024-11-30 | -$2.93K 10-Q · filed 2026-07-13 | -$4.71K derived: sum of 2 quarters · filed 2026-07-13 | -$7.33K derived: sum of 3 quarters · filed 2026-07-13 | -$10.52K derived: sum of 4 quarters · filed 2026-07-13 | |
| 2024-08-31 | -$1.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | -$4.40K derived: sum of 2 quarters · filed 2025-11-28 | -$7.59K derived: sum of 3 quarters · filed 2025-11-28 | -$13.31K 10-K · filed 2025-11-28 | |
| 2024-05-31 | -$2.62K 10-Q · filed 2025-07-14 | -$5.81K derived: sum of 2 quarters · filed 2025-07-14 | -$11.53K 10-Q · filed 2025-07-14 | -$21.22K derived: sum of 4 quarters · filed 2025-07-14 | |
| 2024-02-29 | -$3.19K 10-Q · filed 2025-07-14 | -$8.91K 10-Q · filed 2025-04-14 | -$18.61K derived: sum of 3 quarters · filed 2025-07-14 | -$30.67K derived: sum of 4 quarters · filed 2025-07-14 | |
| 2023-11-30 | -$5.71K 10-Q · filed 2025-07-14 | -$15.41K derived: sum of 2 quarters · filed 2025-07-14 | -$27.47K derived: sum of 3 quarters · filed 2025-07-14 | -$39.98K derived: sum of 4 quarters · filed 2025-07-14 | |
| 2023-08-31 | -$9.70K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | -$21.76K derived: sum of 2 quarters · filed 2024-11-26 | -$34.26K derived: sum of 3 quarters · filed 2024-11-26 | -$47.63K 10-K · filed 2024-11-26 | |
| 2023-05-31 | -$12.06K 10-Q · filed 2024-07-12 | -$24.57K derived: sum of 2 quarters · filed 2024-07-12 | -$37.93K 10-Q · filed 2024-07-12 | -$83.63K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2023-02-28 | -$12.51K 10-Q · filed 2024-07-12 | -$25.87K 10-Q · filed 2024-04-09 | -$71.56K derived: sum of 3 quarters · filed 2024-07-12 | -$106.98K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2022-11-30 | -$13.36K 10-Q · filed 2024-07-12 | -$59.06K derived: sum of 2 quarters · filed 2024-07-12 | -$94.47K derived: sum of 3 quarters · filed 2024-07-12 | -$117.37K derived: sum of 4 quarters · filed 2024-07-12 | |
| 2022-08-31 | -$45.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20 | -$81.11K derived: sum of 2 quarters · filed 2023-11-20 | -$104.00K derived: sum of 3 quarters · filed 2023-11-20 | -$114.33K 10-K · filed 2023-11-20 | |
| 2022-05-31 | -$35.41K 10-Q · filed 2023-07-14 | -$58.31K derived: sum of 2 quarters · filed 2023-07-14 | -$68.63K 10-Q · filed 2023-07-14 | -$193.21K derived: sum of 4 quarters · filed 2023-07-14 | |
| 2022-02-28 | -$22.89K 10-Q · filed 2023-07-14 | -$33.22K 10-Q · filed 2023-04-14 | -$157.79K derived: sum of 3 quarters · filed 2023-07-14 | -$167.35K derived: sum of 4 quarters · filed 2023-07-14 | |
| 2021-11-30 | -$10.32K 10-Q · filed 2023-07-14 | -$134.90K derived: sum of 2 quarters · filed 2023-07-14 | -$144.45K derived: sum of 3 quarters · filed 2023-07-14 | -$155.37K derived: sum of 4 quarters · filed 2023-07-14 | |
| 2021-09-30 | -$10.32K 10-Q · filed 2022-07-14 | ||||
| 2021-08-31 | -$124.57K 10-Q · filed 2022-07-14 | -$134.13K derived: sum of 2 quarters · filed 2022-07-14 | -$145.05K derived: sum of 3 quarters · filed 2022-07-14 | -$159.14K 10-K · filed 2022-11-28 | |
| 2021-05-31 | -$9.55K 10-Q · filed 2022-07-14 | -$20.48K derived: sum of 2 quarters · filed 2022-07-14 | -$34.57K 10-Q · filed 2022-07-14 | -$91.32K derived: sum of 4 quarters · filed 2022-07-14 | |
| 2021-02-28 | -$10.92K 10-Q · filed 2022-07-14 | -$25.01K 10-Q · filed 2021-04-14 | -$81.76K derived: sum of 3 quarters · filed 2022-07-14 | -$111.03K derived: sum of 4 quarters · filed 2022-07-14 | |
| 2020-11-30 | -$14.09K 10-Q · filed 2022-07-14 | -$70.84K derived: sum of 2 quarters · filed 2022-07-14 | -$100.11K derived: sum of 3 quarters · filed 2022-07-14 | -$147.26K derived: sum of 4 quarters · filed 2022-07-14 | |
| 2020-08-31 | -$56.75K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | -$86.02K derived: sum of 2 quarters · filed 2021-11-29 | -$133.17K derived: sum of 3 quarters · filed 2021-11-29 | -$150.62K 10-K · filed 2021-11-29 | |
| 2020-05-31 | -$29.27K 10-Q · filed 2021-07-15 | -$76.42K derived: sum of 2 quarters · filed 2021-07-15 | -$93.87K 10-Q · filed 2021-07-15 | -$131.60K derived: sum of 4 quarters · filed 2021-07-15 | |
| 2020-02-29 | -$47.15K 10-Q · filed 2021-04-14 | -$64.60K 10-Q · filed 2021-04-14 | -$102.33K derived: sum of 3 quarters · filed 2021-04-14 | -$118.46K derived: sum of 4 quarters · filed 2021-04-14 | |
| 2019-11-30 | -$17.45K 10-Q · filed 2021-01-14 | -$55.18K derived: sum of 2 quarters · filed 2021-01-14 | -$71.31K derived: sum of 3 quarters · filed 2021-01-14 | -$76.44K derived: sum of 4 quarters · filed 2021-01-14 | |
| 2019-08-31 | -$37.73K 10-Q · filed 2020-06-29 | -$53.86K derived: sum of 2 quarters · filed 2020-06-29 | -$58.99K derived: sum of 3 quarters · filed 2020-06-29 | -$58.99K 10-K · filed 2020-10-15 | |
| 2019-05-31 | -$16.13K 10-Q · filed 2020-06-29 | -$21.27K derived: sum of 2 quarters · filed 2020-06-29 | -$21.27K 10-Q · filed 2020-06-29 | ||
| 2019-02-28 | -$5.13K 10-Q · filed 2020-06-29 | -$5.13K 10-Q · filed 2020-04-03 | |||
| 2018-08-31 | -$10.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$10.34K derived: sum of 2 quarters · filed 2018-11-14 | -$10.34K derived: sum of 3 quarters · filed 2018-11-14 | -$10.34K 10-K · filed 2018-11-14 | |
| 2018-05-31 | $0.00 10-Q · filed 2018-07-13 | $0.00 derived: sum of 2 quarters · filed 2018-07-13 | $0.00 10-Q · filed 2018-07-13 | -$32.92K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-02-28 | $0.00 10-Q · filed 2018-04-12 | $0.00 10-Q · filed 2018-04-12 | -$32.92K derived: sum of 3 quarters · filed 2018-11-14 | -$37.88K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-11-30 | $0.00 10-Q · filed 2018-01-12 | -$32.92K derived: sum of 2 quarters · filed 2018-11-14 | -$37.88K derived: sum of 3 quarters · filed 2018-11-14 | -$55.08K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-08-31 | -$32.92K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$37.88K derived: sum of 2 quarters · filed 2018-11-14 | -$55.08K derived: sum of 3 quarters · filed 2018-11-14 | -$60.19K 10-K · filed 2018-11-14 | |
| 2017-05-31 | -$4.96K 10-Q · filed 2018-07-13 | -$22.16K derived: sum of 2 quarters · filed 2018-07-13 | -$27.26K 10-Q · filed 2018-07-13 | -$39.58K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-02-28 | -$17.20K 10-Q · filed 2018-04-12 | -$22.31K 10-Q · filed 2018-04-12 | -$34.62K derived: sum of 3 quarters · filed 2018-11-14 | -$40.79K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2016-11-30 | -$5.11K 10-Q · filed 2018-01-12 | -$17.42K derived: sum of 2 quarters · filed 2018-11-14 | -$23.59K derived: sum of 3 quarters · filed 2018-11-14 | -$38.31K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2016-08-31 | -$12.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$18.49K derived: sum of 2 quarters · filed 2018-11-14 | -$33.20K derived: sum of 3 quarters · filed 2018-11-14 | -$62.48K 10-K · filed 2018-11-14 | |
| 2016-05-31 | -$6.17K 10-Q · filed 2017-07-14 | -$20.89K derived: sum of 2 quarters · filed 2017-07-14 | -$50.16K 10-Q · filed 2017-07-14 | -$149.91K derived: sum of 4 quarters · filed 2017-07-14 | |
| 2016-02-29 | -$14.71K 10-Q · filed 2017-04-14 | -$43.99K 10-Q · filed 2017-04-14 | -$143.74K derived: sum of 3 quarters · filed 2017-04-14 | -$187.24K derived: sum of 4 quarters · filed 2017-04-14 | |
| 2015-11-30 | -$29.27K 10-Q · filed 2017-01-13 | -$129.03K derived: sum of 2 quarters · filed 2017-01-13 | -$172.53K derived: sum of 3 quarters · filed 2017-01-13 | -$191.22K derived: sum of 4 quarters · filed 2017-01-13 | |
| 2015-08-31 | -$99.75K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | -$143.25K derived: sum of 2 quarters · filed 2016-11-29 | -$161.95K derived: sum of 3 quarters · filed 2016-11-29 | -$163.85K 10-K · filed 2016-11-29 | |
| 2015-05-31 | -$43.50K 10-Q · filed 2016-07-13 | -$62.19K derived: sum of 2 quarters · filed 2016-07-13 | -$64.10K 10-Q · filed 2016-07-13 | -$64.10K derived: sum of 4 quarters · filed 2016-07-13 | |
| 2015-02-28 | -$18.69K 10-Q · filed 2016-04-13 | -$20.60K 10-Q · filed 2016-04-13 | -$20.60K derived: sum of 3 quarters · filed 2016-04-13 | -$20.60K derived: sum of 4 quarters · filed 2016-04-13 | |
| 2014-11-30 | -$1.91K 10-Q · filed 2016-01-08 | -$1.91K derived: sum of 2 quarters · filed 2016-01-08 | -$1.91K derived: sum of 3 quarters · filed 2016-01-08 | -$1.91K derived: sum of 4 quarters · filed 2016-01-08 | |
| 2014-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $0.00 derived: sum of 2 quarters · filed 2015-11-27 | $0.00 derived: sum of 3 quarters · filed 2015-11-27 | $0.00 10-K · filed 2015-11-27 | |
| 2014-05-31 | $0.00 10-Q · filed 2015-07-14 | $0.00 derived: sum of 2 quarters · filed 2015-07-14 | $0.00 10-Q · filed 2015-07-14 | ||
| 2014-02-28 | $0.00 10-Q · filed 2015-04-14 | $0.00 10-Q · filed 2015-04-14 | |||
| 2013-11-30 | $0.00 10-Q · filed 2015-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |